Intelligent Bio Solutions Inc. (INBS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.831x

Based on the latest financial reports, Intelligent Bio Solutions Inc. (INBS) has a cash flow conversion efficiency ratio of -0.831x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.85 Million) by net assets ($3.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Intelligent Bio Solutions Inc. - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Intelligent Bio Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read INBS liabilities breakdown for a breakdown of total debt and financial obligations.

Intelligent Bio Solutions Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intelligent Bio Solutions Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
E79 Gold Mines Ltd
AU:E79
-0.156x
Spineway
PA:ALSPW
0.023x
Effnetplattformen Holding AB
ST:EFFH
-0.009x
Bullfrog AI Holdings, Inc. Common Stock
NASDAQ:BFRG
-0.570x
Fobi AI Inc
V:FOBI
-0.676x
FRESH FACTORY B.C.
F:Q4Z
N/A
Xylo Technologies Ltd.
NASDAQ:XYLO
-0.007x
The Calmer Co International Ltd
AU:CCO
-6.608x

Annual Cash Flow Conversion Efficiency for Intelligent Bio Solutions Inc. (2017–2025)

The table below shows the annual cash flow conversion efficiency of Intelligent Bio Solutions Inc. from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Intelligent Bio Solutions Inc. worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $2.81 Million $-9.68 Million -3.439x -194.03%
2024-06-30 $8.18 Million $-9.57 Million -1.170x +41.54%
2023-06-30 $3.69 Million $-7.38 Million -2.001x -290.04%
2022-06-30 $6.55 Million $-3.36 Million -0.513x +31.85%
2021-06-30 $15.01 Million $-11.30 Million -0.753x -887.29%
2020-06-30 $-5.21 Million $-498.62K 0.096x -93.18%
2019-06-30 $-3.98 Million $-5.58 Million 1.402x -20.21%
2018-06-30 $-3.06 Million $-5.38 Million 1.758x +4160.83%
2017-06-30 $-5.91 Million $-243.89K 0.041x --

About Intelligent Bio Solutions Inc.

NASDAQ:INBS USA Medical Devices
Market Cap
$21.88 Million
Market Cap Rank
#27847 Global
#5502 in USA
Share Price
$2.41
Change (1 day)
-1.63%
52-Week Range
$0.55 - $17.92
All Time High
$2644.80
About

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more